SYRA
Syra Health Corp.0.0750
+0.0050+7.14%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
895.44KP/E (TTM)
-Basic EPS (TTM)
-0.08Dividend Yield
0%Recent Filings
8-K
Syra names new CEO Alexander
Syra Health appointed Gregory R. Alexander as CEO on December 15, 2025, effective January 5, 2026, with a $251,000 base salary, 30% target bonus, 110,537 RSUs, 257,920 stock options, and 368,458 PSUs tied to performance. The deal includes 6-month severance without cause, accelerated vesting on change of control, plus non-compete. New leader eyes growth.
8-K
Class B transfer rules eased
Syra Health amended its Certificate of Incorporation on November 18, 2025, effective immediately, deleting the automatic Class B conversion upon stockholder death and expanding permitted transfers to immediate family, heirs, successors, and assigns—changes approved by stockholders on November 14. This boosts Class B share liquidity. Amendment filed with Delaware.
8-K
Annual meeting results disclosed
Syra Health held its annual meeting on November 14, 2025, electing five directors—Priya Prasad, Dr. Vijayapal R. Reddy, Dr. Ketan Paranjape, Dr. Avutu S. Reddy, and Radhika Mereddy—despite significant abstentions topping 4.5M votes each. Shareholders ratified M&K CPAs as auditors and approved two charter amendments easing Class B stock transfer rules to family and heirs. Governance intact.
8-K
Q3 revenue dips, margins rise
10-Q
Q3 FY2025 results
Syra Health's Q3 revenue fell 25% y/y to $1.7M (derived), yet gross margin lifted to 33% from 30% on a shift to higher-margin population health ($1.3M, up sharply) over workforce staffing. Operating loss narrowed to $232K from $429K as salaries dropped 43% amid headcount cuts; net loss hit $0.02/share. Cash dipped to $2.0M with $159K operating outflow, $189K notes payable remain. Leadership churned with CEO termination, interim appointment. FSSA drives 59% YTD revenue. Government spending pauses threaten contracts.
IPO
Website
Employees
Sector
Industry
CON
Concentra Group Holdings Parent
19.55-0.33
CYH
Community Health Systems, Inc.
3.25+0.03
EHC
Encompass Health Corporation
108.01+0.42
HCA
HCA Healthcare, Inc.
469.79-7.19
HLYK
HealthLynked Corp.
1.67-0.22
LFST
LifeStance Health Group, Inc.
6.88-0.04
NUTX
Nutex Health Inc.
171.72-4.06
SRXH
SRX Health Solutions, Inc.
0.38+0.07
UHS
Universal Health Services, Inc.
222.64-1.23
WHTCF
Well Health Technologies Corp.
2.89+0.03